• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Sy Mukherjee

Sy Mukherjee is a former health care reporter for Fortune.

Brainstorm Health Daily: May 10, 2017
HealthBrainstorm Health Daily: May 10, 2017
By Clifton Leaf and Sy MukherjeeMay 10, 2017
FRANCE-ECONOMY-PHARMACEUTICALS-SANOFI
HealthThis Drug Company Just Made a Huge Pledge on Its Prices
By Sy MukherjeeMay 9, 2017
559537925
HealthThe FDA Has Approved a Crazy Number of New and Groundbreaking Drugs This Year
By Sy MukherjeeMay 9, 2017
Brainstorm Health Daily: May 9, 2017
HealthBrainstorm Health Daily: May 9, 2017
By Clifton Leaf and Sy MukherjeeMay 9, 2017
175139344
HealthYour Zip Code Is One of the Strongest Indicators of When You’ll Die
By Sy MukherjeeMay 8, 2017
More veterans suffer from ALS, but VA moves to help
HealthThe FDA Just Approved the First New ALS Drug in 22 Years
By Sy MukherjeeMay 8, 2017
Brainstorm Health Daily: May 8, 2017
HealthBrainstorm Health Daily: May 8, 2017
By Clifton Leaf and Sy MukherjeeMay 8, 2017
The Biotech IPO Market May Be Headed for a Comeback
HealthThe Biotech IPO Market May Be Headed for a Comeback
By Sy MukherjeeMay 5, 2017
Brainstorm Health Daily: May 5, 2017
HealthBrainstorm Health Daily: May 5, 2017
By Clifton Leaf and Sy MukherjeeMay 5, 2017
GOP Sets Do-Or-Die Vote To Deliver On Obamacare Repeal Vow
HealthWhy Trumpcare’s Biggest Fans Are Going to Be Disappointed
By Sy MukherjeeMay 4, 2017
Brainstorm Health Daily: May 4, 2017
HealthBrainstorm Health Daily: May 4, 2017
By Clifton Leaf and Sy MukherjeeMay 4, 2017
Guardant Health CEO Helmy Eltoukhy (right)
HealthThis Simple Cancer Test Comes With a Big Caveat
By Sy MukherjeeMay 3, 2017
Fortune Brainstorm Health 2017
HealthGoogle and Facebook Say This Is What’s Holding Back Health Care for the World’s Poorest Kids
By Sy MukherjeeMay 3, 2017
Brainstorm Health Daily: May 3, 2017
HealthBrainstorm Health Daily: May 3, 2017
By Clifton Leaf and Sy MukherjeeMay 3, 2017
Fortune Brainstorm Health 2017
HealthJoe Biden on His New Cancer Initiative, Drug Prices, and Donald Trump
By Sy MukherjeeMay 3, 2017
1...
  • 89
  • 90
  • 91
  • 92
  • 93
...100
Most Popular
Personal Finance
Social Security's 2032 deadline puts a 22% cut on the table — but Washington has way less room to negotiate than 1983placeholder alt text
By John W. Diamond and The ConversationJune 12, 2026
Economy
Boomers actually do hold most of the wealth and power. So why do they call it 'whiny' to point that out?placeholder alt text
By Nick LichtenbergJune 14, 2026
Real Estate
Gen Z fled San Francisco for Texas and Florida. Now they’re turning ‘welcomer cities’ into the next big tech townsplaceholder alt text
By Sydney LakeJune 13, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.